Instil Bio (TIL) Other Working Capital Changes (2022 - 2026)
Instil Bio (TIL) posted quarterly Other Working Capital Changes of -$76000.0 for Q1 2026, up 53.37% year-over-year from -$49552.0 in Q1 2025, and down 105.13% quarter-over-quarter from $1.5 million in Q4 2025.
Instil Bio (TIL) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Instil Bio's Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$76000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 53.37% year-over-year to -$76000.0; the TTM figure through Mar 2026 stood at $8000.0 (up 100.6% YoY), while the FY2025 annual figure was -$79000.0, up 94.26% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$76000.0, down from $1.5 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $5.0 million in Q3 2024, with the low at -$6.5 million in Q1 2025.
- The 5-year median for Other Working Capital Changes is -$841000.0 (2023), against an average of -$397000.0.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes sank 366.67% in 2024, then jumped 487.96% in 2025.
- Instil Bio's Other Working Capital Changes stood at -$335000.0 in 2022, then sank by 315.52% to -$1.4 million in 2023, then jumped by 72.56% to -$382000.0 in 2024, then surged by 487.96% to $1.5 million in 2025, then plunged by 105.13% to -$76000.0 in 2026.
- Business Quant data shows TIL's Other Working Capital Changes at -$76000.0 in Q1 2026, $1.5 million in Q4 2025, and -$51000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Instil Bio | 51.68 Mn | 51.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -75,000.00 |
| Jun 30, 2026 | -75,000.00 |
| Jun 30, 2026 | -75,000.00 |
| Mar 31, 2026 | -76,000.00 |
| Mar 31, 2026 | -76,000.00 |
| Mar 31, 2026 | -76,000.00 |
| Dec 31, 2025 | 1.48 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | -51,000.00 |
| Sep 30, 2025 | -51,000.00 |
| Sep 30, 2025 | -51,000.00 |
| Jun 30, 2025 | -1.35 Mn |
| Jun 30, 2025 | -1.35 Mn |
| Jun 30, 2025 | -1.35 Mn |
| Mar 31, 2025 | -163,000.00 |
| Mar 31, 2025 | -163,000.00 |
| Mar 31, 2025 | -163,000.00 |
| Dec 31, 2024 | -382,000.00 |
| Dec 31, 2024 | -382,000.00 |